- Home
- BDX vs VTR Comparison
BDX vs VTR Comparison
Compare BDX & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDX | VTR |
|---|---|---|
| Founded | 1897 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.0B | 45.0B |
| IPO Year | 1998 | 2005 |
Fundamental Metrics
Financial Performance| Metric | BDX | VTR |
|---|---|---|
| Price | $176.03 | $91.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 13 |
| Target Price | ★ $186.00 | $87.62 |
| AVG Volume (30 Days) | 1.7M | ★ 2.9M |
| Earning Date | 05-07-2026 | 04-27-2026 |
| Dividend Yield | ★ 2.89% | 2.38% |
| EPS Growth | N/A | ★ 184.21 |
| EPS | 0.25 | ★ 0.26 |
| Revenue | ★ $21,840,000,000.00 | $5,833,980,000.00 |
| Revenue This Year | N/A | $14.00 |
| Revenue Next Year | $3.02 | $8.35 |
| P/E Ratio | $682.64 | ★ $355.88 |
| Revenue Growth | 8.24 | ★ 18.47 |
| 52 Week Low | $140.11 | $66.38 |
| 52 Week High | $213.08 | $101.60 |
Technical Indicators
Market Signals| Indicator | BDX | VTR |
|---|---|---|
| Relative Strength Index (RSI) | 72.34 | 49.91 |
| Support Level | $163.44 | $79.49 |
| Resistance Level | $196.05 | $94.60 |
| Average True Range (ATR) | 3.72 | 2.53 |
| MACD | 1.47 | -0.93 |
| Stochastic Oscillator | 96.76 | 34.79 |
Price Performance
Historical ComparisonAbout BDX Becton Dickinson and Company
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.